These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 1745624

  • 21. [Activity of ticarcillin combined with different concentrations of clavulanic acid on 137 Gram-negative bacilli resistant to ticarcillin].
    Aubert G, Dorche G, Frere A, Raby N, Denis M.
    Pathol Biol (Paris); 1987 May; 35(5):537-41. PubMed ID: 3302858
    [Abstract] [Full Text] [Related]

  • 22. [Combined antibacterial activity of clavulanic acid with amoxicillin and ampicillin against Gram-negative strains].
    Mascellino MT, Prignano G, Lorenzi A, Iegri F, Martorano E, Catania S, Ginanni Corradini S.
    Boll Ist Sieroter Milan; 1984 May; 63(5):447-52. PubMed ID: 6335660
    [Abstract] [Full Text] [Related]

  • 23. Sulbactam-containing beta-lactamase inhibitor combinations.
    Akova M.
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():185-8. PubMed ID: 18154545
    [Abstract] [Full Text] [Related]

  • 24. Infection in women. Clinical experience with beta-lactamase inhibitors.
    Holloway WJ.
    J Reprod Med; 1988 Jun; 33(6 Suppl):595-7. PubMed ID: 3294405
    [Abstract] [Full Text] [Related]

  • 25. Newer beta-lactam agents and the Bacteroides fragilis group.
    Cuchural GJ.
    Pharmacotherapy; 1991 Jun; 11(2 ( Pt 2)):51S-55S. PubMed ID: 2041832
    [Abstract] [Full Text] [Related]

  • 26. [Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].
    Fomina IP.
    Antibiot Khimioter; 1997 Jun; 42(12):29-32. PubMed ID: 9480651
    [No Abstract] [Full Text] [Related]

  • 27. Ticarcillin/clavulanate for the treatment of female genital tract infections. Efficacy, safety and comparative microbiology.
    McGregor JA.
    J Reprod Med; 1990 Mar; 35(3 Suppl):333-8. PubMed ID: 2319515
    [Abstract] [Full Text] [Related]

  • 28. [In vitro activity of beta-lactam agents and beta-lactamase inhibitors in clinical isolates of Acinetobacter baumannii].
    López-Hernández S, Alarcón T, Delgado T, de Las Cuevas MC, López-Brea M.
    Rev Esp Quimioter; 1999 Jun; 12(2):140-3. PubMed ID: 10562675
    [Abstract] [Full Text] [Related]

  • 29. Beta-lactamase production and the role of ampicillin/sulbactam.
    Alpuche-Aranda CM.
    Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S8-11; discussion S20-1. PubMed ID: 9519908
    [No Abstract] [Full Text] [Related]

  • 30. Comparative activity in vitro of ticarcillin and ticarcillin plus clavulanic acid against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter calcoaceticus.
    Campos P, Vera A, Martin-Luengo F.
    Chemioterapia; 1987 Jun; 6(2 Suppl):77-8. PubMed ID: 3151358
    [No Abstract] [Full Text] [Related]

  • 31. In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.
    Barry AL, Jones RN, Packer RR.
    J Antimicrob Chemother; 1986 Jan; 17(1):125-7. PubMed ID: 3005222
    [No Abstract] [Full Text] [Related]

  • 32. In-vitro activity of ticarcillin with and without clavulanic acid against clinical isolates of gram-positive and gram-negative bacteria.
    Pulverer G, Peters G, Kunstmann G.
    J Antimicrob Chemother; 1986 May; 17 Suppl C():1-5. PubMed ID: 3636325
    [Abstract] [Full Text] [Related]

  • 33. Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid.
    Casey P, Glauser M.
    Eur J Clin Microbiol; 1983 Dec; 2(6):541-7. PubMed ID: 6607834
    [Abstract] [Full Text] [Related]

  • 34. Susceptibilities of anaerobic gram-negative bacilli to thirteen antimicrobials and beta-lactamase inhibitor combinations.
    Hill GB, Ayers OM, Everett BQ.
    J Antimicrob Chemother; 1991 Dec; 28(6):855-67. PubMed ID: 1816182
    [Abstract] [Full Text] [Related]

  • 35. In vitro evaluations of aminopenicillin/beta-lactamase inhibitor combinations.
    Jones RN.
    Drugs; 1988 Dec; 35 Suppl 7():17-26. PubMed ID: 3265377
    [Abstract] [Full Text] [Related]

  • 36. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.
    Boon RJ, Beale AS, Sutherland R.
    Antimicrob Agents Chemother; 1986 May; 29(5):838-44. PubMed ID: 3524431
    [Abstract] [Full Text] [Related]

  • 37. Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children.
    Citron DM, Goldstein EJ, Kenner MA, Burnham LB, Inderlied CB.
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S356-60. PubMed ID: 7548597
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Beta-lactamase inhibitors from laboratory to clinic.
    Bush K.
    Clin Microbiol Rev; 1988 Jan; 1(1):109-23. PubMed ID: 3060240
    [Abstract] [Full Text] [Related]

  • 40. The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection.
    Powell LL, Wilson SE.
    Surg Infect (Larchmt); 2000 Jan; 1(1):57-63. PubMed ID: 12594910
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.